Revolka

  • about us
  • business
  • technology
  • case studies
  • pipeline
  • investors
  • news
  • contact
  • jp
  • en
    • about us
    • investors
    • faq
    • contact
    • business
    • aiProtein®
    • RevoAb®
    • results
    • pipeline
    • news

contact Let's explore new
possibilities together.

  1. top
  2. News
  3. RevolKa has been selected as a member of the Google for Startups Cloud Program.

2022.11.14

  • news

RevolKa has been selected as a member of the Google for Startups Cloud Program.

Our company has been adopted for the “Google for Startups cloud program” provided by Google.

https://inthecloud.withgoogle.com/startup-ja/dl-cd.html

  • Previous Article
  • Next Article
  • Back to List

Related Articles

  • 2026.06.12

    • news

    RevolKa Director & CSO Prof. Mitsuo Umetsu (Tohoku-Univ.) and Team Announce New AI-Driven Method toAccelerate Discovery of Highly Functional Antibodies

  • 2025.09.09

    • news

    ‘RevoAb™’: A New Service for Antibody Developability Engineering

  • 2025.06.30

    • news

    RevolKa Ltd. Joins Research and Development Program for Innovative Biologics Funded by the Japanese Agency for Medical Research and Development (AMED)

News List

contact Let's explore new
possibilities together.
From solving protein design challenges to joint research,
RevolKa's aiProtein® technology accelerates your business.
Feel free to contact us for a consultation.
Our expert team will propose the optimal solution.
  • Corporate Information

    • about us
    • investors
    • faq
    • contact
  • Business &
    Technology

    • business
    • aiProtein®
    • RevoAb®
  • Information &
    Case Studies

    • case studies
    • pipeline
    • news
Revolka

ページトップへ

  • privacy policy
  • legal notice
  • Cookie Settings

© 2025 RevolKa Ltd. All Rights Reserved.